LadeRx, LLC

Pharmaceutical company · Durham, North Carolina, United States

LadeRx, LLC is a pharmaceutical company headquartered in Durham, North Carolina, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $299,932 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $66,669 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

LadeRx at a glance

Typepharmaceutical company

HeadquartersDurham, North Carolina, United States

SEC CIK1970543

What does LadeRx do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $299,932 in total (2024). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $66,669 sold (2023).

Frequently asked questions about LadeRx

Where is LadeRx headquartered?

LadeRx, LLC is headquartered in Durham, North Carolina, United States.

What does LadeRx do?

LadeRx, LLC is a pharmaceutical company.

Similar companies

Opus Genetics, Inc.Durham, North Carolina, United States
Polarean, Inc.Durham, North Carolina, United States
T3D Therapeutics, Inc.Durham, North Carolina, United States
Chimerix IncDurham, North Carolina, United States
BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
G1 Therapeutics, Inc.Durham, North Carolina, United States
Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States
Tellus Therapeutics, Inc.Durham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences